Management of Cellulitis of the Toe

First-Line Treatment Options

• The Infectious Diseases Society of America recommends cephalexin 500 mg orally four times daily for 5 days as the preferred first-line treatment for uncomplicated cellulitis of the toe, providing excellent coverage against streptococci 1, 2
• Penicillin (250-500 mg orally four times daily) is an alternative first-line option that effectively targets streptococci 2

Alternative Options for Penicillin-Allergic Patients

• For patients with penicillin or cephalosporin allergies, clindamycin 300-450 mg orally four times daily for 5 days is a preferred treatment option 3

When to Consider MRSA Coverage

• MRSA coverage is usually unnecessary for typical cellulitis, but should be considered if the cellulitis is associated with penetrating trauma, purulent drainage, or concurrent evidence of MRSA infection elsewhere 1, 2
• The Infectious Diseases Society of America suggests considering MRSA coverage in patients with nasal colonization with MRSA or systemic inflammatory response syndrome (SIRS) 1, 2

Adjunctive Measures

• Elevation of the affected area to promote gravity drainage of edema and inflammatory substances is recommended 1, 3
• Treatment of predisposing conditions such as tinea pedis, trauma, or venous eczema is also recommended 1, 3

Hospitalization Criteria

• Hospitalization should be considered if there is concern for deeper or necrotizing infection, poor adherence to therapy, or severely immunocompromised patient 2
• The Infectious Diseases Society of America recommends hospitalization for patients with failure of outpatient treatment, systemic inflammatory response syndrome (SIRS), or altered mental status or hemodynamic instability 2

Prevention of Recurrent Cellulitis

• Identifying and treating predisposing conditions such as edema, obesity, venous insufficiency, and toe web abnormalities can help prevent recurrent cellulitis 1
• Prophylactic antibiotics such as oral penicillin or erythromycin twice daily may be considered for patients with 3-4 episodes per year despite addressing predisposing factors 3